PeerJ
 | |
| Discipline | Biology, medicine |
|---|---|
| Language | English |
| Edited by |
|
| Publication details | |
| History | 2013–present |
| Publisher | PeerJ |
| Frequency | Upon acceptance |
| Yes | |
| License | CC BY |
| 3.061 (2021) | |
| Standard abbreviations | |
| ISO 4 | PeerJ |
| Indexing | |
| ISSN | 2167-8359 |
| OCLC no. | 793828439 |
| Links | |
PeerJ is both a for profit, open access, and peer-reviewed scientific mega journal covering research in the biological and medical sciences and the publisher of the journal itself (PeerJ Inc.). The journal officially launched in June 2012, started accepting submissions on December 3, 2012, and published its first articles on February 12, 2013.
In 2024, the firm was acquired by traditional research publisher Taylor & Francis.
PeerJ was originally published by a company of the same name that was co-founded by CEO Jason Hoyt (formerly at Mendeley) and publisher Peter Binfield (formerly at PLOS One), with initial financial backing of US$950,000 from O'Reilly Media's O'Reilly AlphaTech Ventures, and later funding from Sage Publishing.
The firm is a member of CrossRef, CLOCKSS, ORCID, and the Open Access Scholarly Publishers Association. The company's offices are in Corte Madera (California, USA), and London (England, UK). Submitted research is judged solely on scientific and methodological soundness (as at PLoS ONE), with a facility for peer reviews to be published alongside each paper.